Corporate executives execute multi-million dollar stock sales

Several corporate executives have recently executed significant stock sales, according to various SEC filings and reports.

Nebius Group N.V. Chief Revenue Officer Marc Boroditsky liquidated his directly-held Class A shares in a transaction valued at approximately $1.5 million. The sale was conducted under a pre-arranged Rule 10b5-1 trading plan. Despite the sale, Boroditsky retains a stake through 343,000 options.

At Cerebras Systems Inc., Chief Accounting Officer Yagnesh Patel sold 1,320 shares for roughly $269,940 at an average price of $204.50. This transaction, also part of a Rule 10b5-1 plan, reduced his position by 7.92%.

EOG Resources, Inc. COO Jeffrey Leitzell sold 9,039 shares at an average price of $140.61, totaling approximately $1.27 million. This sale was also executed via a Rule 10b5-1 plan.

Abeona Therapeutics Inc. CFO Joseph Vazzano sold 9,191 shares at an average price of $5.16, totaling $47,425. The company noted the sale was intended to cover tax withholding obligations related to equity award vesting.

Finally, BeOne Medicines Ltd. insider Xiaodong Wang sold 31,028 shares at an average price of $364.79, a transaction valued at over $11.3 million. This sale represented a 50% decrease in his position and was performed under a Rule 10b5-1 plan.